ANAB vs ARQT Stock Comparison

ARQT currently leads ANAB in this stock comparison, with AIQ scores of 69 vs 56. The clearest difference is momentum, while ANAB has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 13 points
ANAB
Healthcare
vs
ARQT
Healthcare
ANAB
AnaptysBio, Inc.
Price
$46.25
Day move
-3.18%
AIQ Score
56/100
Best edge
Value
Sector
Healthcare
ARQT
Arcutis Biotherapeutics, Inc.
Leads
Price
$28.26
Day move
+2.65%
AIQ Score
69/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between ANAB and ARQT?

ARQT leads the current stock comparison as Arcutis Biotherapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

AnaptysBio, Inc. vs Arcutis Biotherapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

ARQT leads

ARQT leads by 13 AIQ points, primarily on Momentum and Quality. Wall Street currently favors ANAB on target upside.

Competitive: 2 of 6 evidence groups support ARQT, and its current signal state is conflicted.

Evidence agreement: 2 of 6Comparison trend: Stable
ANAB

AnaptysBio, Inc.

AIQ Score
56/100
AIQ Edge Score
5/10
ARQT

Arcutis Biotherapeutics, Inc.

Leads
AIQ Score
69/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors ARQT over ANAB, 69 versus 56 as of Nov 15, 2026. ARQT's advantage is driven primarily by stronger momentum and quality, while ANAB holds the stronger value profile. ARQT also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ANAB. 2 of 6 covered evidence groups favor ARQT today, and the comparison is rated Competitive on stability: only 2 of 6 covered evidence groups agree. ARQT lead: Stable — the AIQ differential has held near 13 points over 30 sessions.

Compare AnaptysBio, Inc. and Arcutis Biotherapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ANAB
+45.6%
ARQT
+45.9%

Price return comparison

Growth of $10,000, price only

ANAB $14,558 · ARQT $14,590

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ANAB and ARQT against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ANAB advantage
0
ARQT advantage
  • Momentum36 vs 76
    ARQT +40
  • Value74 vs 65
    ANAB +9
  • Quality72 vs 76
    ARQT +4
  • Risk Resilience46 vs 46
    Even

2 of 6 evidence groups favor ARQT. ARQT’s edge is concentrated in momentum and quality; ANAB keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ANAB-1 AIQ

Largest factor move: Value -3

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.22x)
ARQT-1 AIQ

Largest factor move: Momentum -2

New signals

  • ADX Trend Weakening — neutral, trend, medium horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-1.9%)
  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon

ARQT's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — ANAB and ARQT both carry a full feed there.

The central trade-off

ARQT (Arcutis Biotherapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.

ANAB (AnaptysBio, Inc.): the counter-case, on value, fundamentals, valuation.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ARQT

ARQT on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

ARQT

ARQT on combined revenue and EPS growth.

Value

ANAB

ANAB on the peer-relative Value factor, by 9 points.

Momentum

ARQT

ARQT on the Momentum factor, by 40 points.

Lower downside

ANAB

ANAB carries the lower 1-month annualized volatility.

Analyst upside

ANAB

ANAB on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ARQT, analyst targets favor ANAB. That disagreement is the most useful thing on this page.

MeasureANABARQTNote
Implied upside to target+75.1%+51.3%ANAB has more room
Target dispersion+30.9%+21.1%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering88Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 6 covered evidence groups favor ARQT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreARQT56 vs 69
FundamentalsANABon balancerevenue growth 10.1% vs 10.8%; EPS growth -97.9% vs -36.4%; TTM ROE 18.6% vs 3.6%; gross margin 143.7% vs 91.2%; operating margin 34.6% vs 6.9% — ANAB takes 3 of 5 decided legs, not all of them
ValuationANABValue 74 vs 65
TechnicalsARQTPrice vs 50-day -7.1% vs 2.6%; vs 200-day -18.1% vs 11.4%
Risk ResilienceEvenRisk Resilience 46 vs 46
Analyst expectationsANABTarget upside 75.1% vs 51.3%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ANAB and ARQT and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 13 points. (supports the conclusion holding)
  • Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ARQT.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ARQT lead: Stable — the AIQ differential has held near 13 points over 30 sessions.

May 27ANAB leads above the line · ARQT leads belowNov 13
Today
ARQT +13
56 vs 69
7 sessions ago
ARQT +14
57 vs 71
30 sessions ago
ARQT +11
53 vs 64
90 sessions ago
ARQT +4
59 vs 63

The lead changed hands once in this window, most recently on Jul 22 when ARQT moved ahead of ANAB.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ANAB

0 bullish / 3 bearish / 2 neutral

Only ANAB

  • Death Cross Active — bearish, trend, long horizon (13.48%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.22x)
  • Downtrend Structure Active — bearish, trend, long horizon
ARQTConflicted

4 bullish / 1 bearish / 2 neutral, conflicted

Only ARQT

  • Golden Cross Active — bullish, trend, long horizon (8.51%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-1.9%)
  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

ARQT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ANABConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -3.18%, AIQ -1 points).

ARQTDivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +2.65%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ANAB closes the Momentum gap — currently 40 points behind, the largest single contributor to ARQT's edge.
  2. 2ANAB's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ARQT's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ANAB leads on balance
MetricANABARQT
Revenue growth (YoY)10.1%10.8%
EPS growth (YoY)-97.9%-36.4%
Gross margin143.7%91.2%
Operating margin34.6%6.9%
Return on equity (TTM)18.6%3.6%
Debt to equity0.60.47

Performance

ARQT leads 4 of 6 windows
MetricANABARQT
1 week (5 sessions)-0.4%10.6%
1 month (20 sessions)-0.8%-1.9%
3 months (63 sessions)-22.5%10.3%
6 months (126 sessions)-26.8%32.6%
Year to date-4.6%-2.7%
1 year (252 sessions)39.8%20.5%

Technicals

ARQT has the stronger structure
MetricANABARQT
RSI (14)42.748.3
ADX (14)23.724.5
Price vs 50-day-7.1%2.6%
Price vs 200-day-18.1%11.4%
Volatility (1M, annualized)51.8%97.4%

Risk

Split
MetricANABARQT
Beta1.111.47
Sharpe ratio0.780.59
Sortino ratio1.110.85
Max drawdown-35.3%-37.5%
Current drawdown-34.1%-17%
Annualized volatility64.8%56.5%
Value at risk (95%)-5.3%-4.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ANAB or ARQT?

On the Algovestiq AIQ Score, ARQT is the stronger of the two as of Nov 15, 2026, scoring 69 against ANAB's 56. The edge comes from momentum and quality. ANAB is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ANAB or ARQT the better buy right now?

ARQT carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 2 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor ARQT over ANAB?

The composite weights Quality, Value, Momentum and Risk Resilience. ARQT leads Momentum by 40 points; ANAB leads Value by 9 points; ARQT leads Quality by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ANAB or ARQT?

Analyst price targets imply +75.1% upside for ANAB and +51.3% for ARQT, so the Street currently favors ANAB. That points the opposite way to the AIQ Score, which favors ARQT. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ANAB or ARQT?

ANAB is the better-valued of the two on the peer-relative Value factor. ANAB on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ANAB or ARQT?

ARQT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ANAB or ARQT?

ARQT on the Momentum factor, by 40 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ANAB or ARQT?

ANAB is the more resilient of the two, so the other name carries the higher downside risk. ANAB carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ANAB more profitable than ARQT?

ANAB leads on the comparable margin measures — gross margin 143.7% vs 91.2%; operating margin 34.6% vs 6.9%; ttm roe 18.6% vs 3.6%.

Is ARQT's lead over ANAB getting stronger or weaker?

ARQT lead: Stable — the AIQ differential has held near 13 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-07-22, when ARQT moved ahead of ANAB.

What would change the ANAB vs ARQT verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ANAB closes the Momentum gap — currently 40 points behind, the largest single contributor to ARQT's edge; ANAB's Death Cross Active resolves — a bearish trend rule currently active against it; ARQT's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ANAB and ARQT?

ANAB: 0 bullish / 3 bearish / 2 neutral. ARQT: 4 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ANAB is Death Cross Active (bearish, long horizon). On ARQT it is Golden Cross Active (bullish, long horizon).

Compare ANAB and ARQT with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.